Özdemir et al., 2016 - Google Patents
Identification of the T-complex protein as a binding partner for newly synthesized cytoplasmic dynein intermediate chain 2Özdemir et al., 2016
- Document ID
- 15091834021051871469
- Author
- Özdemir A
- Machida K
- Imataka H
- Catling A
- Publication year
- Publication venue
- Biochemical and biophysical research communications
External Links
Snippet
Cytoplasmic dynein is a macromolecular motor complex with diverse functions in eukaryotic cells. Dynein plays essential roles in intracellular transport of organelles and mitosis, mediated in part by interactions between the dynein intermediate chain 2 (IC-2) subunits …
- 102000004169 proteins and genes 0 title abstract description 39
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Taylor et al. | Identification of the proteins, including MAGEG1, that make up the human SMC5-6 protein complex | |
| Xu et al. | Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1 | |
| McKinley et al. | Polo-like kinase 1 licenses CENP-A deposition at centromeres | |
| Bohnenberger et al. | Complex phosphorylation dynamics control the composition of the Syk interactome in B cells | |
| Zhang et al. | Evolutionary development of redundant nuclear localization signals in the mRNA export factor NXF1 | |
| Jiao et al. | Characterization of a central Ca2+/calmodulin-dependent protein kinase IIα/β binding domain in densin that selectively modulates glutamate receptor subunit phosphorylation | |
| US8653039B2 (en) | Peptide based inhibition of caPCNA interaction in cancer | |
| Teakel et al. | Protein complexes including PGRMC1 and actin-associated proteins are disrupted by AG-205 | |
| French et al. | CDK phosphorylation of Xenopus laevis M18 BP 1 promotes its metaphase centromere localization | |
| Rodríguez-Vilarrupla et al. | Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153 | |
| Yu et al. | Amino acids stimulate glycyl‐tRNA synthetase nuclear localization for mammalian target of rapamycin expression in bovine mammary epithelial cells | |
| Loftus et al. | Mechanism for G2 phase-specific nuclear export of the kinetochore protein CENP-F | |
| von Morgen et al. | Nuclear localisation of 53BP1 is regulated by phosphorylation of the nuclear localisation signal | |
| Sekiguchi et al. | Amino acid residues required for Gtr1p‐Gtr2p complex formation and its interactions with the Ego1p‐Ego3p complex and TORC 1 components in yeast | |
| Bieluszewska et al. | PKA‐binding domain of AKAP 8 is essential for direct interaction with DPY 30 protein | |
| Vanselow et al. | Stepwise assembly of the eukaryotic translation initiation factor 2 complex | |
| Kopp et al. | CHIP as a membrane-shuttling proteostasis sensor | |
| Li et al. | Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals | |
| Bober et al. | Identification of new FGF 1 binding partners—Implications for its intracellular function | |
| Zhu et al. | Genetic encoding of 3‐nitro‐tyrosine reveals the impacts of 14‐3‐3 nitration on client binding and dephosphorylation | |
| Prudner et al. | α-Synemin localizes to the M-band of the sarcomere through interaction with the M10 region of titin | |
| Vasou et al. | ISG15‐dependent stabilisation of USP18 is necessary but not sufficient to regulate type I interferon signalling in humans | |
| Tsunematsu et al. | Distinct functions of human MVB12A and MVB12B in the ESCRT-I dependent on their posttranslational modifications | |
| Özdemir et al. | Identification of the T-complex protein as a binding partner for newly synthesized cytoplasmic dynein intermediate chain 2 | |
| Varland et al. | Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae |